PCN35 ECONOMIC EVALUATION OF CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (CHOP) CHEMOTHERAPY REGIME WITH OR WITHOUT RITUXIMAB (R) IN THE 2ND LINE TREATMENT OF FOLLICULAR NON-HODGIN LYMPHOMA

Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66572-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)66572-2/fulltext
Title : PCN35 ECONOMIC EVALUATION OF CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (CHOP) CHEMOTHERAPY REGIME WITH OR WITHOUT RITUXIMAB (R) IN THE 2ND LINE TREATMENT OF FOLLICULAR NON-HODGIN LYMPHOMA
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66572-2&doi=10.1016/S1098-3015(10)66572-2
First page :
Section Title :
Open access? : No
Section Order : 407
Categories :
Tags :
Regions :
ViH Article Tags :